Serum CCL20 may also be used for the detection of hepatocellular carcinoma in HCV-infected patients with comparable specificity and higher sensitivity than Alpha fetoprotein (AFP) 34. This evidence concerns the gene CCL20 and hepatocellular carcinoma.